Are fondaparinux (Arixtra) injections preferable to warfarin (Coumadin) for management of anticoagulation in postoperative hip-fracture patients and those recovering from joint replacement surgery?

The CHMP’s green light for Arixtra (fondaparinux) was based on a review of two large-scale, pivotal Phase III trials involving more than 32,000 patients (OASIS 5 and 6), which demonstrated the drug’s ...

Arnhem, the Netherlands - The FDA has approved fondaparinux sodium (Arixtra® - Sanofi-Synthélabo/Organon) for the prophylaxis of deep vein thrombosis in patients undergoing hip fracture surgery, hip ...

To earn CME related to this news article, click here. January 21, 2009 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise of the potential for ...

PHILADELPHIA, Oct. 2 (UPI) -- GlaxoSmithKline said Monday the U.S. Food and Drug Administration has granted priority review to Arixtra for acute coronary syndromes. The FDA's priority review means the ...

Cancer patients with blood clots -- which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients -- gain no benefit from the insertion of an ...

On the eve of its third-quarter results, shares of Europe's largest drug maker, GlaxoSmithKline , were up $1.02, or 1.8%, to $56.65 in New York after the company said its supplemental new drug ...

> Acambis got the FDA's go-ahead on its smallpox vaccine, a key step in the company's quest for a long-term manufacturing contract with the U.S. government. The company says it's negotiating a deal ...